RANBAXY

Ranbaxy Laboratories Ltd has submitted to the Exchange a copy of the notice of Annual General Meeting of the Company to be held on May 10, 2010. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).<a href=/content/corporate/Ranbaxy_AGMNot_19042010.zip target=NEW> For more details click here.</a>

Ranbaxy Laboratories Ltd has submitted to the Exchange a copy of the Result of Postal Ballot. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/ranbaxy_rpb_22092009.zip target=NEW> For more details click here.</a>

Ranbaxy Laboratories Ltd has submitted to the Exchange a copy of the notice pursuant to section 192A of the Companies Act, 1956 read with the Companies ( passing of the resolution by Postal Ballot ) Rules, 2001. A copy of the notice of the postal ballot shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/ranbaxy_PB_10082009.zip target=NEW> For more details click here.</a>

Ranbaxy Laboratories Ltd has informed the Exchange that the members of the company at the Annual General Meeting (AGM) held on May 29, 2009 have approved : 1) Adoption of audited Profit & Loss Account for the year ended December 31, 2008 and the Balance Sheet as at that date and the Reports of the Directors and the Auditors thereon. 2) Appointment of M/s BSR & Co. as Auditors of the Company to hold office upto the conclusion of the next AGM and authorized the Board of Directors or Committee thereof to fix the remuneration.3) Appointment of Mr. Takashi Shoda as a Director of the Company who wa

Ranbaxy Laboratories Ltd has informed the Exchange that at the Extra-ordinary General Meeting held on July 15, 2008, the shareholders passed a Special Resolution for amendment in the existing Employees Stock Option Scheme of the Company to the effect that maximum number of stock options that may be granted to individual management employee in a year be increased from 40,000 to 3,00,000. Further, the Company has submitted to the Exchange a copy of the special resolution (alongwith Explanatory Statement) passed in the Extra- Ordinary General Meeting held on July 15, 2008. The copy of the same sh

Ranbaxy Laboratories Ltd has informed the Exchange that: "The Members of the Company at the Extra-ordinary General Meeting (EGM) held today i.e. July 15, 2008, have unanimously approved all the Resolutions proposed in the Notice dated June 16, 2008; brief details of the same are given below: 1) Issue of following Securities on a preferential basis to Daiichi Sankyo Company Limited, Japan, as per details given below: a) 46,258,063 fully paid Equity Shares of Rs. 5 each at a premium of Rs. 732 per share; b) 23,834,333 Warrants - each Warrant exercisable between six months to eighteen months from

Ranbaxy Laboratories Ltd has submitted to the Exchange a copy of the notice of the Extraordinary General Meeting of the Company scheduled to be held on July 15, 2008. The copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/ranbaxy_NOTEGM_20062008.zip target=NEW> For more details click here.</a>

Ranbaxy Laboratories Ltd has informed the Exchange that at the Annual General Meeting held on May 30, 2008 the shareholders passed a Special Resolution for amendments to the Employees Stock Options Schemes of the Company. In this regard Company has submitted a copy of the Special Resolution (alongwith Explanatory Statement) passed for amendment of the Employees Stock Options Schemes of the Company pursuant to the SEBI (Employee Stock Option Scheme and Employee Stock Purchase Scheme) Guidelines 1999. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corpo

Ranbaxy Laboratories Ltd has informed the Exchange regarding the outcome of Annual General Meeting held on May 30, 2008. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Ranbaxy_OutBM_30052008.zip target=NEW> For more details click here.</a>

Ranbaxy Laboratories Ltd has informed the Exchange that: "The Members of the Company at the Annual General Meeting held today i.e. May 31, 2007, inter-alia, unanimously approved: 1) Re-appointment of Mr. Vivek Bharat Ram, Dr. P. S. Joshi and Mr. Vivek Mehra as Directors of the Company liable to retire by rotation. 2) Re-appointment of M/s. Walker, Chandiok & Co. as Auditors of the Company and authorized the Board of Directors to fix their remuneration. 3) Appointment of Mr. Atul Sobti as Whole-time Director of the Company for a period of five years effective January 18, 2007, payment of remune

Ranbaxy Laboratories Ltd has submitted to the Exchange a copy of minutes of the AGM of the Company held on June 28,2006. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).

Ranbaxy Laboratories Ltd has submitted to the Exchange a copy of Minutes of EGM of the Company held on October 21, 2005. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Ranbaxy Laboratories Ltd has informed the Exchange of the result of the Postal Ballot conducted in regard to ordinary resolution under section 293 (1) (a) of the Companies Act,1956 authorising the BODs to divest/sell the Allied Businesses portfolio of the Company consisting of (1) Ranbaxy Fine Chemicals Limited (a wholly owned subsidiary), (2) Animal Health Care business and (3) Diagnostic Business. The details of the results of the postal ballot is as follows : (a) No. of valid ballots received in favour of the resolution-5326;(b)No. of votes cast in favour of Resolution- 160,559,936(99.94%);

Ranbaxy Laboratories Ltd has informed the Exchange that the shareholders of the Company at the EGM held on October 21, 2005 have approved the following. (1)Issuance of appropriate securities such as FCCBs and or/ GDRs and / or ADRs and / or any other securities/ instrument upto US Dollars 1500 million or equivalent. (2)Increase in Authorised share capital of the Company from Rs 200 crores to Rs 300 croers and consequential amendments in the Memorandum and Articles of Association. (3)Borrowing in excess of paid up share capital and free reserves of the Company upto Rs 5000 crores (4)Increase in

Ranbaxy Laboratories Ltd has submitted to the Exchange a copy of Notice of EGM of the company to be held on October 21, 2005. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Ranbaxy Laboratories Ltd has submitted to the Exchange a copy of Minutes of the AGM of the Company held on June 30, 2005. The details of the same shall be be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Ranbaxy Laboratories Ltd. has submitted to the Exchange a copy of the notice of AGM of the Company to be held on June 30, 2005. A copy of the notice of the AGM shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).